Rich Pharmaceuticals Inc. (fka RCHA)

[TIMGZ]

https://www.sec.gov/litigation/opinions/2021/34-93260.pdf



UNITED STATES OF AMERICA
before the
SECURITIES AND EXCHANGE COMMISSION
SECURITIES EXCHANGE ACT OF 1934
Release No. 93260 / October 4, 2021
Admin. Proc. File No. 3-20348
In the Matter of
RICH PHARMACEUTICALS, INC.
ORDER REGARDING PREHEARING CONFERENCE
The Securities and Exchange Commission (“Commission”) issued an Order Instituting
Proceedings (“OIP”) on May 27, 2021, pursuant to Section 12(j) of the Securities Exchange Act
of 1934, against Rich Pharmaceuticals, Inc. (“Respondent”).
1 The OIP directed the parties to
conduct a prehearing conference within 14 days of service of Respondent’s answer to the OIP
and, following the conference, to file a statement with the Office of the Secretary advising the
Commission of any agreements reached at said conference.2
If a prehearing conference was not
held, the parties were ordered to file a statement advising the Commission of that fact and of the
efforts made to meet and confer.3 Respondent filed an answer with the Commission on June 11,
2021. The parties have not filed any statement regarding a prehearing conference.
Accordingly, IT IS ORDERED that by October 18, 2021, the parties shall file a statement
with the Office of the Secretary advising the Commission of any agreements reached at the
prehearing conference specified by the OIP. If a prehearing conference was not held, both
parties shall file by that date a statement, jointly or separately, advising the Commission of that
fact and of the efforts made to meet and confer. Pursuant to Rule of Practice 180(c), a party’s
failure to comply with this order may result in the Commission’s determination of the matter at
issue against that party, a finding of waiver, dismissal of the proceeding, or such other sanction
as the Commission finds appropriate.4

1 Rich Pharms., Inc., Exchange Act Release No. 92047, 2021 WL 2182249 (May 27,
2021).
2
Id. at *2
3
Id.
4
17 C.F.R. § 201.180(c).
2
The parties’ attention is directed to the most recent amendments to the Commission’s
Rules of Practice, which took effect on April 12, 2021, and which include new e-filing
requirements.
5
For the Commission, by the Office of the General Counsel, pursuant to delegated
authority.
Vanessa A. Countryman
Secretar